Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» otilimab
otilimab
GSK’s “crown jewels” already look tarnished
EP Vantage
Wed, 11/23/22 - 07:27 am
GSK
Blenrep
Emma Walmsley
daprodustat
gepotidacin
otilimab
Jemperli
Zejula
cabotegravir
GSK dumps major pipeline prospect otilimab on lackluster phase 3 data in rheumatoid arthritis
Fierce Biotech
Thu, 10/27/22 - 10:48 am
GSK
otilimab
rheumatoid arthritis
GSK, after pushing past midphase fail, ends development of otilimab in COVID-19
Fierce Biotech
Wed, 10/27/21 - 11:01 am
GSK
otilimab
COVID-19
clinical trials
GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis
Pharmaceutical Business Review
Sun, 07/7/19 - 11:15 am
GSK
clinical trials
rheumatoid arthritis
otilimab
monoclonal antibodies